CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Short Interest Update

by · The Cerbat Gem

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX – Get Free Report) saw a large increase in short interest during the month of May. As of May 15th, there was short interest totaling 2,549,897 shares, an increase of 70,145.1% from the April 30th total of 3,630 shares. Based on an average daily trading volume, of 57,447,441 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Trading Down 33.3%

Shares of CNBX traded down $0.00 during trading hours on Wednesday, reaching $0.00. The company had a trading volume of 60,582,108 shares, compared to its average volume of 37,521,434. CNBX Pharmaceuticals has a 12-month low of $0.00 and a 12-month high of $0.01.

CNBX Pharmaceuticals Company Profile

(Get Free Report)

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.

See Also